RF. NIV + hypovolemia reduced variability in HR and ICABV by 70-80% (p = 0.002) and doubled ICABF variability (p = 0.03). MAP variability was unchanged in either condition. Respiration-induced HR and ICABV oscillations were in inverse phase and highly coherent (coherence >0.9) during baseline, but this coherence decreased during NIV, in normovolemia and hypovolemia (p = 0.01). Conclusion Controlling respiration in awake healthy humans reduced HR variability and increased CBF variability in hypovolemia and normovolemia. We suggest respiration-induced HR variability to be a mechanism in CBF regulation. Maintaining spontaneous respiration in patients receiving ventilatory support may be beneficial also for cerebral circulatory purposes. Less is known about how heart rate (HR) variability affects CBF. We experimentally reduced respiration-induced HR variability in healthy subjects, hypothesizing that CBF variability would increase. Methods Internal carotid artery (ICA) blood velocity was recorded by Doppler ultrasound in ten healthy subjects during baseline, control-mode, non-invasive mechanical ventilation (NIV), i.e., with fixed respiratory rate, hypovolemia induced by lower body negative pressure, and combinations of these. ICA beat volume (ICABV) and ICA blood flow (ICABF) were calculated. HR, mean arterial blood pressure (MAP), respiratory frequency (RF), and end-tidal CO 2 were recorded. Integrals of power spectra at each subject's RF ± 0.03 Hz were used to measure variability. Phase angle/coherence measured coupling between cardiovascular variables. Results Control-mode NIV reduced HR variability (−56%, p = 0.002) and ICABV variability (−64%, p = 0.006) and increased ICABF variability (+140%, p = 0.002) around Communicated by I. Mark Olfert.
Introduction
Cerebral blood flow (CBF) preservation is an important clinical target in critically ill patients. Traditionally, preserving patient mean arterial blood pressure (MAP) in the plateau region of the CBF autoregulation curve and maintaining normocapnia has been a strategy for ensuring adequate CBF. However, as both arterial blood pressure and the arterial partial pressure of CO 2 (PaCO 2 ) in humans are highly dynamic, there is an increasing interest in CBF variability and its potential clinical significance. CBF variability has been extensively studied in relation with arterial blood pressure variability, to assess the dynamic cerebral autoregulation. Blood pressure variations have been connected to increased stroke incidence, brain damage, and poor health outcomes (Jung and Kim 2013; Shimbo et al. 2012; Tatasciore et al. 2007) . Increased CBF variability is one of the mechanisms thought to underlie the relationship between elevated blood pressure variability and brain dysfunction (Tzeng and MacRae 2013) , and thus to mediate stroke complications in patients (Jung and Kim 2013) .
Cerebral autoregulation is less effective above 0.08 Hz (Zhang et al. 1998 ) and most effective below 0.05 Hz (Claassen et al. 2016) . High-frequency (HF, 0.15-0.4 Hz) oscillations in MAP, resulting from HF oscillations in cardiac output, are thus considered to be transmitted to the brain vasculature. However, little CBF variability is observed in the HF range in spontaneously breathing healthy individuals (Rickards and Tzeng 2014) . Kuo et al. (1998) report an HF component in middle cerebral artery velocity variability, however, constituting only 16% of its total variability; the HF arterial blood pressure variability being approximately 21%. Spontaneous respiration contributes significantly to haemodynamic variability in the HF range (0.15-0.4 Hz), inducing fluctuations in heart rate (HR), left cardiac stroke volume, cardiac output, and MAP (Toska and Eriksen 1993) . The observed low CBF variability, contrasted by the significant respiration-induced hemodynamic variability of the central circulation, leads to the speculation that a regulatory mechanism minimizes CBF variations in the HF interval. Respiratory sinus arrhythmia (RSA), the HR variability (HRV) in the HF interval, has been shown to stabilize cardiac output and thus MAP in the HF range Toska and Eriksen 1993) .
Several modelling methods have been employed to study the effect of beat-to-beat MAP and breath-to-breath endtidal CO 2 (ETCO 2 ) fluctuations on CBF variability (Mitsis et al. 2004; Panerai et al. 2000) . The effect of respiration and HRV on CBF variability, however, is not well documented. Reduced short-term HRV has been observed in patients with cardiovascular and cerebrovascular pathological conditions (Akil et al. 2015; Nagata et al. 2006) . Reduced HRV is an independent prospective marker of stroke risk in healthy individuals (Binici et al. 2011) . Experimentally, HRV can be reduced by control-mode non-invasive ventilatory support (NIV) . The HF spectral power calculated from power spectral analysis is an important tool for measurement of HRV (Larsen et al. 2010) .
The purpose of this study was to examine the effect of spontaneous respiration and HRV on CBF variability during normovolemia and mild hypovolemia. Internal carotid artery blood flow (ICABF) variability at each subject's respiratory frequency (RF) was assessed in relation with the respiration-induced variations in HR and MAP, using frequency domain analysis. Since HRV in the HF range (HF-HRV) during spontaneous breathing has been shown to reduce variations in cardiac output , which directly influences CBF (Ogoh et al. 2005) , we hypothesized that respiratory-induced HRV (RF-HRV) may reduce ICABF variability as well. To test our hypothesis, we trained subjects to accept low-pressure control-mode NIV (i.e., with fixed tidal volume and respiratory rate) to prevent spontaneous initiation of breathing and reduce HRV. The effects of reduced HRV on ICABF were studied both in normovolemia and in hypovolemia induced by lower body negative pressure (LBNP). Hypovolemia and controlled ventilation is a commonly encountered clinical situation, e.g., in the operating theatre; increased CBF variability under these circumstances may affect patient outcome and result in adverse cerebrovascular effects. To the best of our knowledge, the effects of hypovolemia and mechanical ventilation on CBF variability have only been studied separately previously. In this protocol, we investigated their combined effect on ICABF variability.
Materials and methods
Steady-state data from these experiments have been published (Skytioti et al. 2016) . In this study, we investigated the oscillatory responses of the cerebrovascular variables. Fifteen young healthy volunteers were recruited and gave written informed consent to participate in the study. All procedures were performed according to the Declaration of Helsinki. The regional ethics committee approved the protocol and the procedures (no.: 2014 (no.: /2228 (no.: , December 2014 .
None of the subjects was a smoker or taking any medication. The subjects were instructed to abstain from caffeinated beverages and strenuous physical activity for 12 h before the experiment. They also avoided food and drink for 2 h and alcohol for 24 h before the experiment.
We analysed recordings from each subject in four different experimental conditions: spontaneous breathing + normovolemia (baseline), spontaneous breathing + hypovolemia (hypovolemia), control-mode NIV + normovolemia (NIV), and control-mode NIV + hypovolemia. Five subjects were excluded, because we did not obtain technically successful recordings in all four experimental conditions, i.e., at least 2 min of continuous, artefact-free beat-by-beat recordings of all cardiovascular variables. Thus, the analyses presented here are from ten subjects (four males and six females), median age 22 years (range 20-30 years).
Experimental protocol
The experimental protocol is described in detail in a previous paper (Skytioti et al. 2016 ). The experimental challenges were control-mode (i.e. no spontaneous breaths), pressure-regulated, volume-controlled NIV (VIVO50, Diacor a/s, Norway) and LBNP (Hisdal et al. 2003) , alone or in combination. The subjects lay supine in an LBNP chamber wearing a facemask throughout the procedure. During parts of the experiment, NIV was applied with mandatory respiratory frequency, tidal volume, positive end-expiratory pressure (PEEP), and maximal inspiratory pressure set to match each subject's natural respiratory pattern. Spontaneous inspiration was prevented by training the subjects in a preparatory session not to initiate inspiration, but to accept the frequency and tidal volume administered by the ventilator. Ventilator settings [median (range)] were: RF: 14 breaths per min (11-16) and target tidal volume: 650 mL (500-850). Maximum and minimum inspiratory pressures were set to 14 and 4.5 cmH 2 O, respectively, for all subjects. PEEP values of 1.3 cmH 2 O (0.9-1.4) were recorded during normovolemia and 1.2 (0.8-1.4) during hypovolemia. The periods of LBNP [−30 mmHg, induced over 0.3 s (Hisdal et al. 2003) ], generated an acute central blood volume shift corresponding to a depletion of 10-20% of the total blood volume (500-1000 mL) and resulting in mild-to-moderate central hypovolemia (Hisdal et al. 2003 ).
An initial 10-min baseline period of normovolemia was followed by 10 min of simulated central hypovolemia. A 10-min recovery period of normovolemia followed. During each interval, the subjects breathed spontaneously for 5 min and were subjected to control-mode NIV for 5 min (Fig. 1) .
Each subject underwent the procedure twice, with a few minutes' pause between rounds. The first 30-min round was randomized to start with either NIV or spontaneous breathing; in the second round, the sequence was reversed.
Recordings
Mean blood velocity in the ICA (5 MHz probe, insonation angle: 45°, SD-100, Vingmed Sound, Horten, Norway) was recorded beat-by-beat by a trained operator using Doppler ultrasound. ICA was chosen over the widely used middle cerebral artery, because the diameter of the vessel was needed for blood flow calculations. The diameter of the subject's right ICA was measured approximately 2 cm above the bifurcation of the common carotid artery (Willie et al. 2012) before the beginning of the recordings using B-mode Ultrasound (10 and 2.5 MHz, System Five, GE Vingmed Sound, Norway). Non-invasive finger arterial pressure was recorded continuously (Finometer, Finapres Medical System, The Netherlands), and beat-by-beat MAP was calculated by numerical integration. Respiration was recorded breath-by-breath with an elastic belt around the abdomen (Respiration and Body position Amplifier, Scan-Med a/s, Norway). The signal from the belt resulting from the stretch is referred to as respiration. The RF at maximal power was used in the calculations. HR was calculated from the R-R interval in a three-lead ECG sampled at 300 Hz. ETCO 2 in the facemask was recorded by a capnograph (Artema MM201, Artema Medical AB, Sweden). Blood velocity wave, respiration band signal, arterial blood pressure curve, stroke volume (Finometer), LBNP, ETCO 2, and room temperature were sampled at 100 Hz. Mean ICA blood velocity, HR (ECG), and MAP were also sampled beat-by-beat. The recordings were transferred online to a recording computer running dedicated data collection and analysis software (Program for real-time data acquisition, Morten Eriksen, Norway). ICA beat volume (ICABV) was calculated beatby-beat from blood velocity and the diameter of the ICA. NIV Fig. 1 Study protocol displaying subjects' breathing conditions and lower body chamber pressure during 10 min of normovolemia, 10 min of simulated hypovolemia, and 10 min of normovolemiarecovery. This sequence was run twice in each subject, once starting with controlled non-invasive ventilation, i.e., with set respiratory frequency and tidal volume (NIV), and once starting with spontaneous breathing. LBNP lower body negative pressure ICABF was calculated beat-by-beat from ICABV multiplied by instantaneous HR.
Mathematical and statistical analyses
All data were resampled at 4 Hz employing an interpolation scheme. For each experimental condition, we selected a continuous sequence of 2 min after manual inspection for artefacts. The power spectrum, which is a plot of the variance of a time series as a function of frequency, was computed by the Fast Fourier Transform algorithm. The frequency resolution was kept the same in all conditions (~0.0083 Hz). Coherence analysis, which provides a description of the relationship between two fluctuating variables in a specified range of frequencies, was used to examine the association between cardiovascular variables. Using cross-spectral analysis, it is possible to examine whether the variability of two distinct time series is interrelated in the frequency domain. The integrals (area under the curve) of the power spectra were calculated in the subsequent three frequency intervals as estimates of variability in each frequency band. First, respiration-induced variability in cardiovascular variables was calculated at each subject's peak RF ± 0.03 Hz (RF variability). Since spontaneous RF varied between subjects from 0.14 to 0.3 Hz, we moved the RF interval (RF ± 0.03 Hz) accordingly. The percentage of the total respiration power included in the RF ± 0.03 Hz interval was calculated on the signal from the Respiration and Body position Amplifier. In spontaneous breathing states, this interval included almost 80% of the respiration power [normovolemia: 77% (56-85%) and hypovolemia: 78% (65-85%)]. During control-mode NIV all respiration power was included in the RF ± 0.03 Hz interval.
Integrals were also calculated for the HF interval (0.15-0.4 Hz, HF variability), which is widely used for the study of respiratory variability. Third, the total variability in the interval 0.05-0.5 Hz was calculated to quantify the changes in respiratory-induced variability of the cardiovascular variables relative to the overall variability. The relative RF variability of each cardiovascular variable was then calculated as the fraction of the RF variability (RF ± 0.03 Hz) to the total variability.
Interaction between cardiovascular variables was examined by computing phase angles and coherence from the cross-spectra at peak RF (RF ± 0.02 Hz), for the following pairs of variables: respiration-HR, respiration-ICABV, respiration-ICABF, HR-ICABV, and MAP-ICABF. The phase angle is the time delay between two waves that oscillate at the same frequency. Coherence provides a measure of the coupling between two signals over the range of frequencies examined.
Averaged phase angles were calculated by weighting the phase angles with their squared coherence. Two oscillating variables were considered to be in phase when the absolute phase difference between them was less than 45° (0.79 rad) and in inverse phase when the absolute phase difference was more than 135° (2.35 rad). Waves that meet in antiphase weaken each other, a phenomenon called destructive interference. This has been observed for HR and cardiac stroke volume at the RF, in effect diminishing cardiac output oscillations (Toska and Eriksen 1993) .
Numbers are medians and 95% confidence intervals (95% CI) calculated by Hodges-Lehmann's estimate if not otherwise specified. For illustration purposes, integrals calculated for each experimental condition were also normalized with respect to the median value during baseline. Wilcoxonmatched-pairs signed-rank test against a two-sided alternative (Hollander and Wolfe 1999) was used to test the differences in ICABF variability between conditions (StatXact, Cytel Studio 10, Cytel Inc., Cambridge, MA, USA) and the level of significance was set at p = 0.05 before analysis. In addition, we report the p values (calculated after analysis) for the change in variability of the rest of the cardiovascular variables for informative purposes.
Results
All ten subjects completed the protocol successfully and tolerated the abruptly induced central hypovolemia without signs of presyncope. The ten subjects complied successfully with the ventilator; they did not initiate inspiration, but accepted passively the fixed respiratory rate and tidal volume administered by the ventilator. ETCO 2 was decreased during control-mode NIV due to the slight hyperventilation which was necessary to diminish spontaneous inspiratory effort. However, ETCO 2 and RF were stable during each of the 2-min time intervals selected for frequency analysis in each experimental condition.
Raw data from one subject (recordings of ICABF, HR and ICABV) during the procedure are presented in Fig. 2 . Table 1 shows steady-state values of the studied variables during the four different experimental states.
Cerebrovascular variability during baseline
Synchronous high-amplitude oscillations in HR and ICABV were observed during baseline, whereas little variability was observed in ICABF over the respiratory cycle (Figs. 2, 3a) . Inspiration coincided with an increase in HR and a decrease in ICABV, and expiration with a decrease in HR and an increase in ICABV (Fig. 3a) .
The total, HF, and RF variabilities in HR and ICABV were maximal during spontaneous breathing + normovolemia (Table 2 ; Fig. 4a ). The relative RF-HRV was 39% (23-45%) of the total variability (measured over the entire 0.05-0.5 Hz interval). Thus, respiration-centered HRV is an important part of HRV. In contrast, the relative RF-ICABF variability during baseline constituted only 13% (11-15%) of the total ICABF variability. Table 3 shows the changes in phase angle and coherence between the conditions for the chosen pairs of variables. Respiration and HR oscillations were in phase and highly coherent (median coherence 0.93). Respiration was in inverse phase and highly coupled with ICABV oscillations (median coherence 0.94). Similarly, HRV and ICABV oscillations were in inverse phase and highly coherent (median coherence 0.90), the increases in HR coinciding with drops in ICABV (Fig. 2a) . These effects were also demonstrated by the power spectra, where maximum power was observed for HR and ICABV at the RF during baseline. In contrast, small variability in MAP and ICABF was observed (Fig. 5a) .
Coherence between MAP and ICABF was very low during spontaneous breathing + normovolemia (Table 3) , the condition when both these variables reached their lowest variability. Low coherence may indicate a nonlinear relationship, an absence of a relationship between two signals (Zhang et al. 1998) , or a low signal-to-noise ratio, which is common with spontaneous oscillations (Claassen et al. 2009 ).
Effect of control-mode NIV on cerebrovascular variability
A significant drop in HRV in all frequency bands, in HF-ICABV variability, and in RF-ICABV variability occurred during control-mode NIV (Table 2 ; Fig. 4b ). Relative RF-HRV was 33% (12-40%), similar to during baseline. The decrease in the respiratory-induced oscillations of HR and ICABV is also depicted in Fig. 3b .
RF-ICABF variability increased during control-mode NIV by about 140% (Table 2 ; Fig. 4b ). In eight out of ten subjects, a peak in the power spectrum of ICABF was observed at the set RF (Fig. 5b) ; this peak was absent during spontaneous breathing. A similar peak at the set RF was observed for MAP variability in six of the ten subjects (Fig. 5b) . The relative RF-ICABF variability was increased to 33% (24-37%, p = 0.002), compared to 13% at baseline.
Despite the reduction in RSA magnitude during controlmode NIV, respiration and HR oscillations remained in phase and were highly coherent (median coherence 0.91). In Fig. 2 Recordings (raw data) from one subject during 10 min of normovolemia and 10 min of simulated hypovolemia induced by lower body negative pressure, with and without non-invasive control-mode ventilatory support (NIV). During spontaneous breathing + normovolemia, there were large synchronous fluctuations in heart rate (HR) and internal carotid artery beat volume (ICABV) but minimal oscillations in internal carotid artery blood flow (ICABF). Controlled mechanical ventilation and hypovolemia, separately and combined, reduced HR and ICABV oscillations ) 1.0 (0.6-1.4) 1.1 (0.5-2.0) 1.9 (0.7-4.6) 1.7 (0.6-2.5) ICABV (mL contrast, coherence between respiration and ICABV as well as between HR and ICABV decreased (Table 3) compared to during baseline.
Effect of hypovolemia on cerebrovascular variability
Both HF-ICABV variability and RF-ICABV variability decreased during hypovolemia (Table 2 ; Fig. 4c ). The relative RF-HRV was 36% (19-44%). ICABF variability did not change with hypovolemia in either frequency interval. The relative RF-ICABF variability was 18% (14-21%), slightly increased from baseline (p = 0.05). RSA was maintained during hypovolemia (HR in phase with respiration and highly coherent, Table 3 ). ICABV oscillations was in inverse phase and highly coherent with both respiration and HR oscillations (Table 3) .
Effect of combined control-mode NIV and hypovolemia on cerebrovascular variability
HF-HRV and RF-HRV were about 70-80% lower during control-mode NIV + hypovolemia than during baseline, as was HF-and RF-ICABV variability (Table 2 ; Fig. 4d ). In contrast, RF-ICABF variability increased by about 100%. The relative RF-HRV was 22% (10-37%) of the total, i.e., lower than during baseline, and the relative RF-ICABF variability was 24% (6-30%).
During combined control-mode NIV and hypovolemia, an increased respiratory component in ICABF variability appeared around the set RF in eight out of ten subjects (Fig. 5d) , similar to during NIV in normovolemia. No such peak in ICABF variability was present during baseline or during hypovolemia alone, i.e., in conditions with spontaneous breathing. A similar peak in MAP variability at the set RF was observed in seven of the ten subjects (Fig. 5d ), but on a group level, MAP variability did not differ significantly between experimental conditions in either frequency interval (Table 2 ; Fig. 4d ).
Coherence and phase angle between respiration and HR did not change, indicating the presence of RSA though with a low magnitude. In contrast, the coherence between respiration and ICABV, HR, and ICABV and respiration and ICABF reached their lowest values in this state (Table 3) .
Discussion
In the present study, we evaluated respiratory-induced HRV as a possible regulatory mechanism of CBF and examined the effect of respiratory variations on CBF during combined control-mode NIV and hypovolemia. We found that respiratory-induced ICABF variability in spontaneously breathing subjects was minimal, constituting only a small fraction of total ICABF variability both during normovolemia and hypovolemia. Control-mode NIV reduced respiratory HRV and increased respiratory variability in ICABF, during normovolemia and hypovolemia. We suggest that respiratory HRV during spontaneous breathing minimizes CBF variability. This finding might be of clinical importance as increased CBF variability has been connected to adverse cerebrovascular events. During spontaneous breathing, HRV counteracted ICABV fluctuations, as drops in ICABV coincided with increases in HR during inspiration, and vice versa during expiration, thus minimizing fluctuations in ICABF. In contrast, during control-mode NIV with mandatory set RF and tidal volume, respiration-induced variability in ICABF was increased by 140% during NIV + normovolemia and 100% during NIV + hypovolemia. The coupling between respiration-induced oscillations in ICABV and HR decreased markedly during control-mode NIV (both in normovolemia and hypovolemia), from the situation of highly coupled, inversephase oscillations during spontaneous breathing + normovolemia. Our study thus demonstrates a connection between decreased respiration-induced HRV and increased ICABF variability that may be of clinical relevance.
Both cardiac stroke volume and cardiac output have been shown to be linearly related to middle cerebral artery blood velocity (Bronzwaer et al. 2014; Ogoh et al. 2005) . Increased oscillations in these variables could, therefore, be linearly transmitted to middle cerebral artery blood velocity and thus to CBF. We demonstrated that despite respirationsynchronous oscillations in ICABV during spontaneous breathing, ICABF variability was minimal due to buffering of the ICABV variability by HRV, which stabilized ICABF over the respiratory cycle.
Possible physiological roles of RSA have been investigated both in humans and animal models. Artificially induced RSA in a dog model optimized gas exchange and oxygen transport and reduced intrapulmonary shunt (Hayano et al. 1996) , but this could not be demonstrated in humans (Tzeng et al. 2009 ). RSA has also been shown to buffer respiratory variability in left cardiac output, thus stabilizing MAP and systemic flow (Elstad 2012; . Minimization of cardiac work has been proposed as another function of RSA (Ben-Tal et al. 2012) . We here suggest minimization of respiration-related CBF variability as an additional physiological role of RSA.
In the present study, control-mode NIV reduced RSA substantially compared to the physiologic setting of spontaneous breathing. The main mechanism for this decrease in RSA was probably the reduction in the central feed-forward drive due to the elimination of spontaneous inspiratory effort (Beda et al. 2012; . The positive intrathoracic pressure during NIV may have affected the pulmonary and cardiac stretch receptors. In pigs, controlled mechanical ventilation reduced RSA amplitude and cardioventilatory coupling compared to assisted mechanical ventilation (Beda et al. 2012) . Our study thus, in line with the previous reports, shows that controlled mechanical ventilation reduces RSA, making control-mode NIV a good protocol to explore the effects of RSA on ICABF variability in human subjects.
Hypovolemia exaggerates the effects of positive pressure ventilation on the circulation. The combination of hypovolemia and control-mode mechanical ventilation is frequent in the operating theatre and not uncommon among critical care patients; thus, our findings of increased variability in cerebrovascular flow under such circumstances are of interest. Because HRV decreases during hypovolemia , the combination of controlled ventilation and hypovolemia was hypothesized to induce a larger drop in RSA. This hypothesis was verified (Table 2) . However, despite a greater reduction in RSA during control-mode NIV + hypovolemia than during NIV alone, CBF variability in our study was similar in these two states.
Positive pressure ventilation and PEEP may affect cardiac stroke volume by impeding right ventricular filling. Our study employed very low PEEP settings that did not likely impact stroke volume much. In contrast, hypovolemia induced by LBNP reduced stroke volume markedly (Skytioti et al. 2016) .
It has been argued that increased CBF oscillations are not necessarily harmful for the brain (Rickards and Tzeng 2014) . Increased middle cerebral artery velocity oscillations have been suggested to delay presyncopal symptoms during progressive hypovolemia in subjects breathing through an inspiratory threshold device (Rickards et al. 2007 ). Amplification of the respiratory pump with the inspiratory threshold device produced increased oscillations in CBF velocity in their study; resembling the high-amplitude respirationinduced ICABV oscillations, we observed during baseline (Figs. 1, 2a) . In contrast, the use of control-mode NIV in the present study prevented spontaneous respiration and reduced the spontaneous RF-and HF-ICABV variability. Concurrently, an increased respiratory variability component appeared in ICABF.
During control-mode NIV, RF-ICABF variability increased, and a decrease in coupling between HR and ICABV was observed. The relative RF-ICABF variability was also higher during controlled than spontaneous breathing, indicating that the respiratory-induced CBF variations became a more important component of total CBF variability during controlled ventilation. Both the decreased coupling between HRV and ICABV variability and the cyclic changes in intrathoracic pressure during NIV may have been responsible for the increase in RF-ICABF variability. The effects of mechanical ventilation on the circulation are more pronounced the higher the mean airway pressure, as higher intrathoracic pressure impedes venous return and decreases right ventricular filling. Hypovolemia will exaggerate these effects (Cheifetz 2014) . However, while each cyclic increase in intrathoracic pressure increases right ventricular afterload, it also improves left ventricular filling and decreases left ventricular afterload. Thus, during hypovolemia, mechanical ventilation induces larger respiratory oscillations in cardiac output (Michard 2005; Rimehaug et al. 2016) , and these may be transferred to the CBF. We demonstrated an increase in RF-ICABF variability during control-mode NIV. Increased variability in MAP and cardiac output may have contributed, though we were unable to demonstrate this in our study.
Clinical implications
HRV is affected by several pathophysiological conditions. Reductions in HRV have been associated with poor clinical outcomes after acute myocardial infarction (Balanescu et al. 2004 ) and have been reported to be a predictor of poststroke mortality (Makikallio et al. 2004 ). Several studies have linked lower HRV with brain dysfunction (Biswas et al. 2000; Katz-Leurer et al. 2014; Kholod et al. 2013) . A decrease in HRV was associated with cerebrovascular pathology in normotensive diabetic patients (Nagata et al. 2006) .
In healthy spontaneously breathing subjects, minimal variability is observed in CBF (Kuo et al. 1998; Rickards et al. 2007) . We found that ICABF oscillations increased around the set RF during control-mode NIV, both in normovolemia and in hypovolemia. This observation could be of clinical importance as it may indicate that CBF regulation might be disturbed by the applied therapy in patients treated with controlled mechanical ventilation for extended periods of time. Elderly patients in particular may be more vulnerable, also due to a higher prevalence of medical comorbidities. A recent study indicated an association between impaired intraoperative CBF autoregulation and postoperative cognitive dysfunction in patients over 65 years (Goettel et al. 2017) .
Associations between cerebral pathology and exaggerated blood pressure variations have been reported and possible underlying mechanisms are larger CBF fluctuations, neurohumoral activation, endothelial dysfunction, inflammatory mediators, and oxidative stress (Jung and Kim 2013; Shimbo et al. 2012; Tatasciore et al. 2007 Tatasciore et al. , 2008 . Optimizing intravascular volume, avoiding excess sedation, and using lung-protective ventilation strategies with supported rather than controlled ventilation may contribute to improved cerebral outcomes in critical care patients.
Considerations
CBF is highly dependent on PaCO 2 (Panerai et al. 2010 ) and any kind of physical stimulation. The experiments were performed in a quiet room, in resting subjects who had familiarized themselves with the equipment and procedures. To minimize confounding factors, we recorded ETCO 2 as an estimate of the PaCO 2 and ensured that there were no significant changes during each 2-min time interval selected for frequency analysis in each experimental state. However, there was a decrease in ETCO 2 from baseline to NIV and to NIV + hypovolemia. Since ETCO 2 necessarily can be determined only once per breath, we could not study the effect of ETCO 2 fluctuations on ICABF variability in the HF range. To evaluate whether cyclical changes in arterial partial pressure of CO 2 actually affect CBF would require continuous invasive measurements. It has been shown that the effect of breath-by-breath ETCO 2 fluctuations on the middle cerebral artery blood flow velocity is considerable in the very low frequencies and in the low frequencies, implying that slow variations in ETCO 2 have a larger impact on middle cerebral artery blood flow velocity (Mitsis et al. 2006) . Mitsis et al. showed that ETCO 2 variations have a considerable effect on CBF at frequencies below 0.04 Hz (Mitsis et al. 2004) . Taking into account the negligible effect of ETCO 2 in the HF range, we assumed that ETCO 2 fluctuations did not affect cerebrovascular respiratory variability.
Another methodological concern was whether the diameter of the ICA, which was measured once in the beginning of each experiment, remained stable throughout the experiment or changed in response to changes in ETCO 2 and LBNP. PaCO 2 change <1.3 kPa is considered unlikely to cause ICA diameter changes (Sato et al. 2012; Willie et al. 2012) , and no change in ICA diameter was reported between baseline and −35 mmHg LBNP (Ogoh et al. 2015) . As the largest change in ETCO 2 in our experiments was 1.1 kPa and the LBNP level was −30 mmHg we assumed that ICA diameter remained the same.
We calculated RF variability at subjects' peak RF ± 0.03 Hz in addition to in the HF interval. In spontaneously breathing subjects, the RF varies with time, and therefore, spontaneous respiratory variability may be widely distributed. To take this into account, we calculated the percentage of the total respiration power (respiration signal) included in the RF ± 0.03 Hz interval. Almost 80% of the respiration power was included. During control-mode NIV with or without hypovolemia, all respiratory variability was included in the RF ± 0.03 Hz interval. The measured change in RF-HRV would probably have been larger if it Fig. 5 Power spectra (HF interval: 0.15-0.4 Hz) of cardiovascular variables during four states (a baseline: spontaneous breathing + normovolemia, b NIV: control-mode NIV + normovolemia, c hypovolemia: spontaneous breathing + hypovolemia, and d control-mode NIV + hypovolemia), in the same subject, as shown in Figs. 2 and 3 . The RF interval (0.24-0.3 Hz) is noted. HR heart rate, ICABV internal carotid artery beat volume, ICABF internal carotid artery blood flow, MAP mean arterial pressure, RF-SPONT spontaneous respiratory frequency, RF-NIV set respiratory frequency during controlled noninvasive ventilation ◂ was calculated over a wider interval during spontaneous breathing.
Our findings during NIV directly apply only if conditions are similar, i.e., healthy subjects, no sedation or paralytics, marginal PEEP, controlled respiratory rate, and low-grade pressures. The subjects did not initiate inspiration, but our study design did not hinder diaphragmatic muscle activity participating in the respiratory cycle. Thus, the applied interventions were milder than those often used in clinical settings, where more pronounced effects of controlled mechanical ventilation would be expected. This is suggested also by animal studies (Beda et al. 2012) .
Conclusion
Respiratory and cardiovascular variability may introduce changes in cerebral hemodynamics despite several counteracting mechanisms, such as the cerebral autoregulation of CBF. We suggest that respiration-induced HRV could be an additional mechanism that contributes to stabilization of short-term CBF variability in spontaneously breathing, healthy individuals. A reduction in HRV, experimentally induced in our study by control-mode NIV, was accompanied by a significant increase in CBF variability in both normovolemia and mild hypovolemia.
